Potential CD27-CD70 interaction within adoptive T cells does not affect tumor antigen–specific T-cell immunotherapy
ImmunoHorizons · 2026
DOI: 10.1093/immhor/vlaf086 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2026. Verfasst von Eswara Rao Puppala und 7 weiteren Autor:innen. Beteiligte Einrichtung: Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, United States. Hauptthemen laut MEDLINE: CD27 Ligand, Tumor Necrosis Factor Receptor Superfamily, Member 7, Immunotherapy, Adoptive, T-Lymphocytes. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The CD27-CD70 pathway regulates T-cell activity either positively or negatively depending on the context of immune response. Typically, CD27 is known as a co-stimulatory receptor expressed on T cells while CD70 is the ligand expressed on antigen-presenting cells. Interestingly, CD70 is also expressed on T cells upon activation, raising an intriguing question about whether potential CD27-CD70 interaction within T cells affects T-cell response. To address this question in an antigen-specific adoptive T-cell model for tumor immunotherapy, we bred Pmel transgenic mice (JAX strain: 005023) with Cd70-/- mice to generate Pmel-Cd70-/- mice. We found that both CD27 and CD70 are expressed on Pmel T cells activated by GP100 antigen in vivo. Interestingly, T cells expressed CD27 protein at higher frequencies and higher levels in Pmel-Cd70-/- mice compared to Pmel mice with intact Cd70 gene, indicating CD27-CD70 reciprocal regulation. We inoculated Cd27-/-Cd70-/- mice with B16-F10 melanoma cells, then adoptively transferred Pmel versus Pmel-Cd70-/- T cells to compare their efficacy in controlling tumor growth. This unique system eliminates CD27-CD70–mediated interaction between host cells and adoptive T cells, allowing us to distinguish the impact of potential CD27-CD70 interaction within adoptive T cells. Our results showed that Pmel and Pmel-Cd70-/- T cells exhibited significant yet equivalent efficacy in inhibiting tumor growth, indicating that potential CD27-CD70 interaction within adoptive T cells does not affect T-cell immunotherapy in this tumor model. This work is informative for designing adoptive T-cell therapy for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, United States.
- Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, United States.
ORCID-Profile: Eswara Rao Puppala, Mohammad A Alzubi, Xuefang Cao
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute Cancer Center
- University of Maryland Greenebaum Comprehensive Cancer Center
Zitieren
APA
Puppala, E. R., Alzubi, M. A., Mustapha, H. A., Basu, S., Choi, C. Y., Wu, L., Fan, X., & Cao, X. (2026). Potential CD27-CD70 interaction within adoptive T cells does not affect tumor antigen–specific T-cell immunotherapy. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf086
Vancouver
Puppala ER, Alzubi MA, Mustapha HA, Basu S, Choi CY, Wu L, et al. Potential CD27-CD70 interaction within adoptive T cells does not affect tumor antigen–specific T-cell immunotherapy. ImmunoHorizons. 2026. doi:10.1093/immhor/vlaf086
BibTeX
@article{Puppala2026,
author = {Puppala, Eswara Rao and Alzubi, Mohammad A and Mustapha, Habeebat Aderonke and Basu, Sayon and Choi, Chang-Yong and Wu, Long and Fan, Xiaoxuan and Cao, Xuefang},
title = {Potential CD27-CD70 interaction within adoptive T cells does not affect tumor antigen–specific T-cell immunotherapy},
journal = {ImmunoHorizons},
year = {2026},
doi = {10.1093/immhor/vlaf086}
}
EUVIMED